Bethanechol

Régine Béliard Veillard, Pharm.D., BCACP TTS, Stacy Elder Dalpoas, Pharm.D., BCPS, Lipika Samal, M.D.
Bethanechol is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Urinary Retention: Treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention

NON-FDA APPROVED USES

  • Neurogenic bladder
  • Gastroparesis
  • Alzheimer’s disease
  • Gastric reflux
  • Gastric atony or adyamic ileus
  • Erectile dysfunction
  • Motion sickness
  • Stuttering
  • Treatment of disabling anticholinergic adverse effects or anticholinergic syndrome from medications such as tricyclic antidepressants

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Urinary Retention: Treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention

NON-FDA APPROVED USES

  • Neurogenic bladder
  • Gastroparesis
  • Alzheimer’s disease
  • Gastric reflux
  • Gastric atony or adyamic ileus
  • Erectile dysfunction
  • Motion sickness
  • Stuttering
  • Treatment of disabling anticholinergic adverse effects or anticholinergic syndrome from medications such as tricyclic antidepressants

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: February 6, 2022